Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 963 | 3,659 | 3,743 | 3,654 | 3,488 |
| Gross Profit | 963 | 3,659 | 3,743 | 3,654 | 3,488 |
| Operating Expenses | 4,959 | 4,829 | 6,144 | 8,722 | 6,687 |
| Operating Income | -3,996 | -1,170 | -2,402 | -5,068 | -3,199 |
| Interest Expense | 47 | 57 | 70 | 78 | 90 |
| Other Income | -561 | 781 | 243 | 733 | -628 |
| Pre-tax Income | -4,603 | -446 | -2,229 | -4,413 | -3,917 |
| Income Tax | 25 | -7 | 30 | 12 | 29 |
| Net Income Continuous | -4,628 | -439 | -2,258 | -4,425 | -3,946 |
| Net Income | $-4,628 | $-439 | $-2,258 | $-4,425 | $-3,946 |
| EPS Basic Total Ops | -24.02 | -3.00 | -12.01 | -27.03 | -24.02 |
| EPS Basic Continuous Ops | -23.58 | -2.41 | -12.79 | -26.18 | -22.71 |
| EPS Diluted Total Ops | -24.02 | -3.00 | -12.01 | -27.03 | -24.02 |
| EPS Diluted Continuous Ops | -23.58 | -2.41 | -12.79 | -26.18 | -22.71 |
| EBITDA(a) | $-3,959 | $-1,134 | $-2,362 | $-5,024 | $-3,155 |